NEW YORK (GenomeWeb News) – BGI has acquired 27 SOLiD 4 instruments and will offer human genome sequencing on the platform under a partnership with Life Technologies announced today.
The acquisition will allow BGI, formerly called Beijing Genomics Institute, to sequence 50 whole genomes a month, they said in a joint statement.
Li Jingxiang, vice president of genomics operations for BGI, added that with the instruments, BGI will be able to generate sequencing data for a complete whole human genome at 30-fold coverage that includes 100 gigabases of mapped data at 99.9 percent accuracy.
Financial terms of the deal were not disclosed.
During Life Tech's third quarter earnings this week, the company reported record sales for the SOLiD 4 platform.